abagovomab 55
abciximab 50
abituzumab 36
abrilumab 33
actoxumab 40
adalimumab 23
aducanumab 21
afasevikumab 24
alacizumab_pegol 17
alemtuzumab 46
alirocumab 27
amatuximab 60
andecaliximab 38
anifrolumab 38
anrukinzumab 21
aprutumab 28
aprutumab_ixadotin 28
arcitumomab 34
ascrinvacumab 25
atezolizumab 18
atinumab 25
avelumab 24
basiliximab 59
bavituximab 55
begelomab 53
benralizumab 44
bevacizumab_beta 27
bezlotoxumab 40
bimagrumab 37
bleselumab 40
blinatumomab 55
blosozumab 43
bococizumab 35
brazikumab 26
brentuximab_vedotin 52
briakinumab 27
brodalumab 33
brolucizumab 33
brontictuzumab 40
burosumab 40
cabiralizumab 43
camrelizumab 17
canakinumab 32
cantuzumab_ravtansin 61
carlumab 30
carotuximab 41
cergutuzumab_amunaleukin2 36
cergutuzumab_amunaleukin 36
certolizumab_pegol 29
cetiximab 53
citatuzumab_bogatox 35
cixutumumab 51
clivatuzumab_tetraxetan 37
codrituzumab 44
conatumumab 29
concizumab 38
crenezumab 28
crizanlizumab 40
crotedumab 31
dacetuzumab 26
daclizumab 31
dalotuzumab 46
dapirolizumab_pegol 30
daratumumab 18
dectrekumab 15
demcizumab 44
denosumab 14
depatuxizumab 37
depatuxizumab_mafodotin 37
dezamizumab 39
dinutuximab 50
diridavumab 37
domagrozumab 19
drozitumab 28
duligotuzumab 22
durvalumab 18
dusigitumab 42
efalizumab 40
efungumab 38
eldelumab 24
elezanumab 42
elgemtumab 17
elotuzumab 22
emactuzumab 37
emapalumab 33
emibetuzumab 35
enavatuzumab 30
enfortumab_vedotin 21
enoblituzumab 26
enokizumab 38
enoticumab 27
ensituximab 53
eptinezumab 23
erenumab 37
etaracizumab 20
etrolizumab 27
evinacumab 28
evolocumab 37
farletuzumab 13
fasinumab 37
fezakinumab 44
fibatuzumab 32
ficlatuzumab 37
firivumab 42
flanvotumab 34
fletikumab 49
foralumab 22
foravirumab 22
fremanezumab 36
fresolimumab 28
fulranumab 27
futuximab 46
galcanezumab 34
ganitumab 42
gantenerumab 19
gemetuzumab 47
gemtuzumab2 42
gemtuzumab 54
gevokizumab 38
girentuximab 42
glembatumumab 38
glembatumumab_vedotin 38
guselkumab 39
ibalizumab 39
ibritumomab 59
icrucumab 18
idarucizumab 52
ifabotuzumab 32
imalumab 20
imgatuzumab 39
inclacumab 27
indatuximab_ravtansin 44
indusatumab 33
inebilizumab 37
intetumumab 21
iodine_girentuximab 35
ipilimumab 12
iratumumab 36
isatuximab 47
itolizumab 33
ixekizumab 46
labetuzumab_govitecan 30
lambrolizumab 44
lampalizumab 35
lanadelumab 24
landogrozumab 25
laprituximab 46
lebrikizumab 46
lendalizumab 41
lenzilumab 37
lifastuzumab_vedotin 26
ligelizumab 36
lilotomab 47
lirilumab 43
lodelcizumab 34
lokivetmab 34
lorvotuzumab_mertansin 29
lucatumumab 37
lumretuzumab 32
lupartumab 26
lutikizumab 22
margetuximab 46
milatuzumab 51
mirvetuximab 50
mirvetuximab_soravtansin 50
modotuximab 61
mogamulizumab 34
monalizumab 40
motavizumab 45
moxetumomab_pasudotox 33
namilumab 41
naratuximab 51
naratuximab_emtansin 51
narnatumab 23
navicixizumab2 39
navicixizumab 45
navivumab 51
necitumumab 33
nemolizumab 43
nesvacumab 18
nivolumab 23
obiltoxaximab 36
obinutuzumab 44
ocaratuzumab 39
ofatumumab 27
olaratumab 40
olokizumab 29
omalizumab 28
onartuzumab 28
ontuxizumab 42
opicinumab 19
orticumab 20
otelixizumab 41
oxelumab 19
ozanezumab 49
pamrevlumab 17
panobacumab 29
parsatuzumab 34
pasotuxizumab 24
pateclizumab 23
patritumab 38
pembrolizumab 44
perakizumab 28
pidilizumab 33
pinatuzumab_vedotin 23
plozalizumab 31
pogalizumab 41
polatuzumab_vedotin 27
ponezumab 53
prezalumab 19
pritoxaximab 54
quilizumab 22
racotumomab 49
radretumab 21
ralpancizumab 38
ramucirumab 22
ranevetmab 37
ranibizumab 27
refanezumab 33
remtolumab 23
rilotumumab 35
rinucumab 34
risankizumab 43
rituximab 44
rivabazumab 28
robatumumab 22
roledumab 36
romosozumab 38
rontalizumab 30
rosmantuzumab 40
rozanolixizumab 26
sacituzumab 39
sacituzumab_govitecan 39
samalizumab 42
sapelizumab 41
sarilumab 24
secukinumab 25
seribantumab 23
setoxaximab 57
sifalimumab 27
siltuximab 34
simtuzumab 45
sirukumab 19
solanezumab 31
solitomab 43
stamulumab 38
suptavumab 33
suvizumab 28
tabalumab 35
tadocizumab 31
tamtuvetmab 43
tanezumab 36
tarextumab 15
tavolixizumab 33
telisotuzumab 43
teplizumab 34
tesidolumab 40
tezepelumab 38
tigatuzumab 17
tildrakizumab 39
timolumab 21
tisotumab 19
tosatoxumab 51
tositumomab 56
tralokinumab 49
trastuzumab 28
tregalizumab 28
trevogrumab 21
ublituximab 53
urelumab 39
ustekinumab 37
utomilumab 43
vadastuximab 45
vadastuximab_talirin 45
vandortuzumab_vedotin 28
vantictumab 30
vanucizumab2 27
vanucizumab 55
varlilumab 22
vatelizumab 45
vedolizumab 46
veltuzumab 38
vesencumab 16
vorsetuzumab 38
vorsetuzumab_mafodotin 38
vunakizumab 52
xentuzumab 26
zatuximab 61
